EVENTS:   Mining the Data - What the Iran Conflict Really Means for Oil - 3-month vs. 12-month Outlook - Kathleen Kelley/Queen Anne's Gate Capital - 19 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Chinese Equity Ideas & Channel Checks Across 50 sub-sectors

23 - 27 Mar 2026

London

Horizon Insights
Don Ma Don Ma Chief strategist and co-founder Chief strategist and co-founder. He has in-depth understanding and research experience in Chinese A-share markets analysis and equity research.
Long Short European Equity Research

26 Mar 26

New York

The Analyst
Harry Grist Harry Grist
Fundamental US Healthcare Short Ideas

27 Mar 26

London

Favus Institutional Research
Dr Elliot Favus Dr Elliot Favus CEO & Senior Analyst Dr. Favus is a pharmaceutical equity research specialist with buyside and sellside experience, including Senior Analyst roles at Och Ziff and Lazard. Earlier in his career, Dr. Favus spent 10 years working on human genetics projects at Harvard Medical School and the University of Chicago.
Independent Analysis on Active Fund Positioning, Fund Flows and Peer Group Fund Analysis

06 - 10 Apr 2026

London

Copley Fund Research
Steven Holden Steven Holden Founder & CEO Steven brings over 18 years of experience across global equity and emerging markets. His background includes senior roles at Morgan Stanley and Citigroup in London and Hong Kong, specialising in derivatives, global markets, and emerging markets.